These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30279786)

  • 1. Improvement of pulmonary arterial hypertension following medication and shunt closure in a
    Suzuki H; Hanawa H; Torigoe T; Sato S
    J Cardiol Cases; 2017 Jul; 16(1):11-13. PubMed ID: 30279786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.
    Takaya Y; Akagi T; Sakamoto I; Kanazawa H; Nakazawa G; Murakami T; Yao A; Nanasato M; Saji M; Hirokami M; Fuku Y; Hosokawa S; Tada N; Matsumoto K; Imai M; Nakagawa K; Ito H
    Heart; 2022 Mar; 108(5):382-387. PubMed ID: 34415851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.
    D'Alto M; Romeo E; Argiento P; Correra A; Santoro G; Gaio G; Sarubbi B; Calabrò R; Russo MG
    Int J Cardiol; 2013 Oct; 168(4):3797-801. PubMed ID: 23850317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device closure of atrial septal defect with severe pulmonary hypertension in adults: Patient selection with early and intermediate term results.
    Dalvi B; Jain S; Pinto R
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):309-315. PubMed ID: 30346095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of preoperative oxygen saturation as a predictor of pulmonary arterial hypertension after surgery of atrial septal defects.
    Park HK; Shin HJ; Park YH; Ma BG
    Interact Cardiovasc Thorac Surg; 2016 Sep; 23(3):424-30. PubMed ID: 27222001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter Closure of Atrial Septal Defect Associated With Pulmonary Artery Hypertension using Fenestrated Devices.
    Wang JK; Chiu SN; Lin MT; Chen CA; Lu CW; Wu MH
    Am J Cardiol; 2021 May; 147():122-128. PubMed ID: 33667439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Treat-to-close": Non-repairable ASD-PAH in the adult: Results from the North American ASD-PAH (NAAP) Multicenter Registry.
    Bradley EA; Ammash N; Martinez SC; Chin K; Hebson C; Singh HS; Aboulhosn J; Grewal J; Billadello J; Chakinala MM; Daniels CJ; Zaidi AN
    Int J Cardiol; 2019 Sep; 291():127-133. PubMed ID: 31031077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan.
    Liang KW; Chang SK; Chen YW; Lin WW; Tsai WJ; Wang KY
    Front Cardiovasc Med; 2022; 9():911649. PubMed ID: 35811711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.
    Fujino T; Yao A; Hatano M; Inaba T; Muraoka H; Minatsuki S; Imamura T; Maki H; Kinugawa K; Ono M; Nagai R; Komuro I
    Int Heart J; 2015; 56(1):86-93. PubMed ID: 25742945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of medical therapy for pulmonary hypertension and delayed atrial septal defect closure.
    Bradley EA; Chakinala M; Billadello JJ
    Am J Cardiol; 2013 Nov; 112(9):1471-6. PubMed ID: 23993122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of the right heart and the preoperative factors that influence the emergence PAH after surgical closure of atrial septal defect.
    Supomo S; Widhinugroho A; Nugraha AA
    J Cardiothorac Surg; 2020 May; 15(1):105. PubMed ID: 32434521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prediction model of simple echocardiographic variables to screen for potentially correctable shunts in adult patients with pulmonary arterial hypertension associated with atrial septal defects: a cross-sectional study.
    Li M; Wang Y; Li H; Huang Y; Huang T; Zhang C; Fei H
    Int J Cardiovasc Imaging; 2021 May; 37(5):1551-1562. PubMed ID: 33528711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy of a Genetic Analysis of the BMPR2 Gene in a Patient with Severe Pulmonary Arterial Hypertension and an Atrial Septal Defect Treated with Bilateral Lung Transplantation.
    Tatebe S; Sugimura K; Aoki T; Yamamoto S; Yaoita N; Suzuki H; Sato H; Kozu K; Konno R; Satoh K; Fukuda K; Adachi O; Saito R; Nakanishi N; Morisaki H; Oyama K; Saiki Y; Okada Y; Shimokawa H
    Intern Med; 2017 Dec; 56(23):3193-3197. PubMed ID: 29021450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter closure of atrial septal defect protects from pulmonary edema: septal occluder device gradually reduces LR shunt.
    Murakami T; Nakazawa G; Horinouchi H; Torii S; Ijichi T; Ohno Y; Amino M; Shinozaki N; Ogata N; Yoshimachi F; Yoshioka K; Ikari Y
    Heart Vessels; 2017 Jan; 32(1):101-104. PubMed ID: 27314266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: A systematic review.
    Zwijnenburg RD; Baggen VJM; Geenen LW; Voigt KR; Roos-Hesselink JW; van den Bosch AE
    Am Heart J; 2018 Jul; 201():63-71. PubMed ID: 29910057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treat and Repair Strategy in Patients With Atrial Septal Defect and Significant Pulmonary Arterial Hypertension.
    Kijima Y; Akagi T; Takaya Y; Akagi S; Nakagawa K; Kusano K; Sano S; Ito H
    Circ J; 2016; 80(1):227-34. PubMed ID: 26567484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of a middle-aged patient with a ventricular septal defect complicated by severe pulmonary hypertension-stepwise surgical repair with pulmonary vasodilators.
    Kanai A; Koitabashi N; Akagi S; Sorimachi H; Ishibashi Y; Nagasaka T; Takama N; Soma K; Yao A; Kasahara S; Kurabayashi M
    J Cardiol Cases; 2021 Sep; 24(3):131-135. PubMed ID: 34466177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary blood flow alters nitric oxide production in patients undergoing device closure of atrial septal defects.
    Tworetzky W; Moore P; Bekker JM; Bristow J; Black SM; Fineman JR
    J Am Coll Cardiol; 2000 Feb; 35(2):463-7. PubMed ID: 10676695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsequent shunt closure after targeted medical therapy can be an effective strategy for secundum atrial septal defect with severe pulmonary arterial hypertension: two case reports : strategy for ASD with severe PAH.
    Taniguchi Y; Emoto N; Miyagawa K; Nakayama K; Kinutani H; Tanaka H; Shinke T; Okada K; Okita Y; Hirata KI
    Heart Vessels; 2014 Mar; 29(2):282-5. PubMed ID: 23595779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in Patients with Pulmonary Arterial Hypertension Underwent Transcatheter Closure of an Atrial Septal Defect.
    Seol JH; Jung SY; Lee HB; Kim AY; Kim EH; Min IK; Kim NK; Choi JY
    J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.